Posts in Government

Inter partes review proceedings unconstitutionally assign to an Article I executive branch tribunal matters reserved for Article III Judges that make up the Federal Judiciary. This is in violation of Separation of Powers principles, which is particularly problematic given that we are talking about property rights being stripped from patent owners by administrative law judges in a proceeding designed to be a district court alternative. These administrative tribunals also adjudicate patent validity without a jury, in violation of patentees’ Seventh Amendment rights.

Earlier today 40 economists and law professors wrote to Senate and House Judiciary leaders explaining that the data it that keeps being cited to justify HR 9, otherwise known as the Innovation Act, is “flawed, unreliable and incomplete.” The professors caution Congress to proceed cautiously, particularly given the numerous misleading and flawed studies that “highly exaggerated claims regarding patent trolls.”

Sadly, this is not an isolated case. I’ve seen similar rejections in a diverse (and utterly random) number of art areas and technologies ranging from predictive computer algorithms, to voice recognition technology, to methods for user-customization of advertising received on a device. While some of the rejected claims were arguably directed to an abstract idea, only a small minority had any apparent connection to “organizing human activity” as that phrase has been used in the case law.

Earlier today the United States Senate confirmed Michelle Lee to head the United States Patent and Trademark Office, a position that has been vacant since the resignation of David Kappos at the end of January 2013. Lee’s official title will be Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office.

According to Congressman Collins, who I spoke with via telephone on Friday, March 6, 2015, there was a great deal of treatment of the SEA at the subcommittee level during the 113th Congress, but now during the 114th Congress consideration will move to the full Committee level, which suggests a seriousness about getting something done. ”Music licensing will be an area where something bubbles up this Congress,” Collins explained. ”I’m hoping the industry will come together.”

With an eye toward taking a step forward on the regulatory front, on Sunday, February 15th, the U.S. Federal Aviation Industry released a proposed framework of regulations for unmanned aircraft systems (UAS), or drones, that the agency and many drone operators are hopeful will lead to the greater incorporation of drones into American airspace. However, some of the proposed regulations would effectively squash certain commercial applications of drone aircraft being developed by Amazon and others, or at least postpone them for the time being.

The issue of proper due process is critical, according to Johnson, because “the PTAB is now both deciding on the institution of and the conduct of these IPRs and PGRs, and of course, they’re issuing the final decisions.” There is no doubt that given their outsized authority, the way the PTAB has evolved is reminiscent of a tribunal that acts as judge, jury, and executioner. At times I am also reminded of the old Westerns where a particularly vile villain would be apprehended. The crowd would scream for him to be hanged and some law abiding Sheriff would appear and say something like: “No! We are going to give this man a fair trial and then we are going to hang him!”

Carly Fiorina: ‘[W]atch carefully who is supporting that [the Innovation Act]. It’s not the small it’s the big. It’s the big companies whose ongoing economic benefit depends upon their ability to acquire innovations and patents at a lower cost.”

Senator Coons: ”[P]atents are not just foundational. Patents are really about the American Dream. They are about what it means to come to this country or be from this country and believe in the possibility that you and a team of folks that you work with can invent and develop and then protect a groundbreaking innovation. Patents are about constantly laying a stronger foundation upon which future generations can continue to innovate and about insuring we will find solutions to the challenges that face us, not just here but around the world… So here is the truth. We need to both strengthen patents and target real abuse. They are not mutually exclusive…”

An effort to address bad actors may unnecessarily create significant hurdles for innovators seeking to enforce or license the rights to their own innovations. The fear of unintended consequences requires targeted reform that will specifically address only the abusive behaviors relied upon by the bad actors, namely misleading and fraudulent demand letters. The trick will be to tackle these abusive behaviors that serve no legitimate purpose while not making legitimate business communications impossible. Luckily, it is not difficult to spot fraudulent demand letters and distinguish them from legitimate business inquiries. But will Congress be able to strike the appropriate legislative solution?

The company that just forcefully promised to fight the troll at all costs now can’t write the check fast enough. The case settles, the corporation feels vindicated because they didn’t have to pay their high priced attorneys for more than a couple hours, and they have mitigated the risk. This story is repeated constantly, but one thing never changes. Because the case was settled there is no prevailing party. Therefore, there will never be an award of attorneys fees against the nefarious actors that are rightly called patent trolls.

The STRONG Patents Act appears to be overwhelmingly favorable to innovators and patent owners. This legislation stands in stark contrast with the Innovation Act submitted in the House by Congressman Bob Goodlatte (D-Va) and shows a very different, alternative vision for the patent system.

The summit will bring together entrepreneurs, business leaders, academics, government officials, and thought leaders in the innovation ecosystem to engage on how government, academia, and industry can work together to spur economic growth. The event will include panels on the evolving role of urban innovation in the American economy, the role of government and universities in technology development, and discussions on what investors and startups want to see in developing policy around innovation.

The USPTO has put SAWS to rest, literally. The USPTO has posted a message on the agency’s website explaining that after conducting an internal review of the SAWS program the agency has ”decided to retire this program.” Furthermore, the USPTO explained that ”[a]ny applications currently in this program will now proceed through prosecution absent any additional SAWS-related processing.”

There have been signs that Samsung is trying to wind down its operations in its medical device businesses, but we found plenty of patent applications filed with the USPTO indicating that healthcare innovation is still very important to this corporation. A technique for the genetic analysis of human subjects to test for diagnosing certain leukemias is featured by U.S. Patent Application No. 20150038360, titled Method for Multiplex-Detecting Chronic Myelogenous Leukemia Gene Using Cleavable Probe. The kit for detecting an e19a2 breakpoint of a BCR-ABL fusion gene claimed here contains five primer sets, each having a primer comprised of a specific nucleic acid. This kit provides for the early detection of chronic myelogenous leukemia, or CML, including rarer varieties of the disease.